CNS Disorders  >>  Octagam (intravenous normal human immunoglobulin)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Octagam (intravenous normal human immunoglobulin) / Octapharma
2012-005086-12: Study to investigate the ability of a blood-derived score to select patients with relapsing multiple sclerosis who benefit from treatment with human immune globulin

Ongoing
3
81
Europe
Rebif 44 micrograms, Betaferon 250 microgram/ml, Extavia 250 microgram/ml, Octagam 50 mg/ml, Copaxone 20 mg/ml, Rebif 44 micrograms, Betaferon 250 microgram/ml, Extavia 250 microgram/ml, Octagam 50 mg/ml, Copaxone 20 mg/ml, Rebif 44 micrograms, Betaferon 250 microgram/ml, Extavia 250 microgram/ml
Octapharma AG, Octapharma AG
relapsing multiple sclerosis
 
 
NCT00545493: Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen Encephalitis

Unknown status
2/3
16
Europe
Tacrolimus, Prograf, i.v. immunoglobulins, Octagam
University Hospital, Bonn, Octapharma, Astellas Pharma GmbH
Rasmussen Encephalitis
04/10
04/10
ATTEND, NCT03829566: Autologous Transplant To End NMO Spectrum Disorder

Withdrawn
2/3
0
US
Rituximab, Rituxan, Cyclophosphamide, Cytoxan, Mesna, Mesnex, rATG, Thymoglobulin, Anti-Thymocyte Globulin, Methylprednisolone, Solu-Medrol, Depo-Medrol, G-CSF, Neupogen, Filgrastim, Granix, Zarxio, IVIg, Bivigam, Carimune Nanofiltered (NF), Gammagard, Privigen, Octagam, Autologous Stem Cells
Northwestern University
Neuromyelitis Optica, Devic's Disease, NMO Spectrum Disorder
01/25
11/25

Download Options